Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HSBC posts better-than-expected Q4 profit, plans $2bn of share buybacks

(Sharecast News) - HSBC Holdings beat analysts' profit estimates and unveiled a fresh share buyback programme. Reported revenues fell by 11% during the fourth quarter to reach $11.6bn, with the lender citing the recycling of FX losses and other reserves related to the divestment of its Argentine unit as the causes of that.

Reported profit before tax meanwhile was ahead by $1.3bn to $2.3bn or by $0.4bn to $0.6bn on an after tax basis.

Commenting on HSBC's results, chief executive officer Georges Elhedery said that the group's "strong" full-year performance set the stage for future growth.

"We are creating a simple, more agile, focused bank built on our core strengths. We continue to take deliberate and decisive steps," he added.

In constant currency terms, and excluding notable items, HSBC's topline grew by $1.2bn to $16.5bn during the quarter on a reported basis.

As regards the global economic outlook, HSBC said that it was still uncertain, with possible downside risks from trade frictions and supply disruptions.

Management reiterated a previous forecast for a return on tangible equity in the mid teens for each of the three years between 2025 and 2027, when excluding notable items.

But in a research note sent to clients, analysts at RBC Capital Markets noted how consensus was for a 14% return.

Hence RBC's expectation that the medium-term RoTE guidance would be in focus during HSBC's conference call, according to Dow Jones Newswires.

For their part, analysts at Keefe, Bruyette & Woods labelled HSBC's fourth quarter figures as "respectable".

The lender also announced that it was planning to start a share buyback programme of as much as $2.0bn.

But KBW said that felt "light" in comparison to the recent $3bn run rate, although the proposed dividend was "slightly better".

They also took aim at the premium valuation, arguing that "to say that Asia/Hong Kong is the same opportunity as it was 15 year ago is obviously flawed."

As of 0902 BST, shares of HSBC were off by 1.10% at 880.20p, having earlier briefly traded in the black.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.